Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00030901 | S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate | completed | Phase 3 | 619 | SWOG Cancer Research NetworkNETWORK | 0 | Feb 6, 2013 | clinicaltrials |
| NCT00265070 | Trial of Iressa in Prostate Cancer Patients | completed | Phase 2 | 80 | AstraZenecaINDUSTRY | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00433446 |
| S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy |
| completed |
| Phase 2 |
| 62 |
| SWOG Cancer Research NetworkNETWORK |
| 1 |
| Feb 5, 2013 |
| clinicaltrials |
| NCT00040755 | BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00004929 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00005632 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | completed | Phase 1 | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00276549 | Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 35 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00688532 | Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not | completed | — | 5,103 | AstraZenecaINDUSTRY | 0 | Jan 31, 2013 | clinicaltrials |
| NCT00939510 | Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 32 | Robert Dreicer MDOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00003832 | Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00096499 | SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00109811 | Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00919477 | Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg(CAMON) | completed | — | 712 | AstraZenecaINDUSTRY | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00006044 | Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00020891 | CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy | completed | Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00147212 | ET 743 (Yondelis) in Men With Advanced Prostate Cancer | completed | Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00289341 | Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. | completed | Phase 1 / Phase 2 | 24 | Rockefeller UniversityOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00738673 | Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer | completed | Phase 2 | 37 | Ferring PharmaceuticalsINDUSTRY | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00014352 | Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00059943 | Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00004879 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00071968 | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | completed | Phase 2 | 15 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00090363 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | completed | Phase 2 | 447 | AstraZenecaINDUSTRY | 14 | Jan 8, 2013 | clinicaltrials |
| NCT00967018 | A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 77 | Ferring PharmaceuticalsINDUSTRY | 7 | Jan 3, 2013 | clinicaltrials |
| NCT00773305 | Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer | completed | — | 200 | Summa Health SystemOTHER | 0 | Dec 28, 2012 | clinicaltrials |
| NCT00295750 | The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer | completed | Phase 3 | 620 | Ferring PharmaceuticalsINDUSTRY | 12 | Dec 19, 2012 | clinicaltrials |
| NCT00299741 | Study of SU11248 in Men With Advanced Prostate Cancer | completed | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00923416 | Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events | completed | — | 240 | University Health Network, TorontoOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT01752140 | A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme | completed | N/A | 463 | Hospital de Santa Maria, PortugalOTHER | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00623090 | Internet-Based Education for Prostate Cancer Screening(PCSEd) | completed | Phase 3 | 1,893 | Georgetown UniversityOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00564928 | A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer(IPI-504-04) | completed | Phase 2 | 19 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 11, 2012 | clinicaltrials |
| NCT01441713 | Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer | completed | — | 178 | Copenhagen University Hospital at HerlevOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT00684905 | Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy | completed | Phase 2 | 50 | Mayo ClinicOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01024959 | Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result(PCA3) | completed | N/A | 507 | Gen-Probe, IncorporatedINDUSTRY | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00005048 | Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00616291 | Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer | completed | Phase 1 | 14 | Baylor College of MedicineOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00900406 | Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant | completed | — | 190 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT01191931 | Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)(PHS-02) | completed | — | 52 | Advanced Medical Diagnostics s.a.INDUSTRY | 5 | Oct 29, 2012 | clinicaltrials |
| NCT00084825 | Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 | completed | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00771966 | Radical Prostatectomy and Perioperative Fluid Therapy | completed | Phase 4 | 44 | Rigshospitalet, DenmarkOTHER | 1 | Oct 22, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00002511 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,005 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00658229 | The Physical Exercise and Prostate Cancer Study(PEPC) | completed | Phase 3 | 60 | Oslo University HospitalOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT00080678 | Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases | completed | Phase 2 | 116 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 12, 2012 | clinicaltrials |
Data updated 24 days agoSource updated Feb 6, 2013source: clinicaltrials